Your session is about to expire
Vigamox vs Tobradex
Introduction
For patients dealing with bacterial eye infections, certain prescription medications can be very effective in alleviating symptoms and treating the root cause of the infection. Vigamox and Tobradex are two such drugs that are commonly prescribed for these types of conditions. Both have different active ingredients but serve a similar purpose — to combat harmful bacteria in the eye. Vigamox is an antibiotic called moxifloxacin, which works by preventing bacterial cells from dividing and repairing, thus killing them off over time. On the other hand, Tobradex is a combination drug consisting of an antibiotic (tobramycin) that combats bacteria coupled with a corticosteroid (dexamethasone) that reduces inflammation.
Vigamox vs Tobradex Side By Side
| Attribute | Vigamox | Tobradex |
|---|---|---|
| Brand Name | Vigamox | Tobradex |
| Contraindications | Should not be used with contact lenses. Remove lenses before application and wait 15 minutes before reinsertion. | Should not be used with contact lenses. Remove lenses before application and wait at least 10 minutes before reinsertion. |
| Cost | Around $180 for a 3 ml bottle; generic options range from about $50 to $110 | About $200 for a similar quantity; generic options cost around $70 to $150 |
| Generic Name | Moxifloxacin | Tobramycin/Dexamethasone |
| Most Serious Side Effect | Signs of an allergic reaction, eye pain or changes in vision, severe burning, stinging, itching or redness after applying the eye drops. | Signs of an allergic response, eye pain, redness, discomfort or sensitivity to light, vision changes, drainage from your eye that is yellow or green in color. |
| Severe Drug Interactions | Not specified, but it's important to inform your physician about all medications you're currently using. | Oral steroids may increase intraocular pressure when taken concurrently. |
| Typical Dose | One drop in the affected eye(s) three times a day for seven days. | 1-2 drops into the affected eye every 4 hours. Can be increased to every two hours during the initial 24 to 48 hours if necessary. |
What is Vigamox?
Moxifloxacin (the generic name for Vigamox) is a fourth-generation fluoroquinolone antibiotic, an advancement from earlier generations of antibiotics. It was first approved by the FDA in 1999. Vigamox works by inhibiting bacterial DNA replication enzymes, effectively disrupting their growth and "trapping" them from further multiplication. It is prescribed mainly for the treatment of bacterial eye infections such as conjunctivitis. Moxifloxacin has a broad-spectrum antibacterial activity with minimal influence on human cells, resulting in it having fewer side effects than other antibiotics that have stronger effects on these cells.
On the other hand, Tobradex contains two active ingredients: Tobramycin, an aminoglycoside antibiotic; and Dexamethasone, a corticosteroid which helps to reduce inflammation. This combination makes Tobradex effective not just against bacteria but also at reducing associated inflammation caused by infection or injury.
What conditions is Vigamox approved to treat?
Vigamox is approved for the treatment of various ocular bacterial infections:
- Bacterial conjunctivitis, also known as pink eye
- Corneal ulcers caused by susceptible bacteria
- Post-operative infection prophylaxis in cataract surgery
How does Vigamox help with these illnesses?
Vigamox is an antibiotic eye drop that works by halting the growth of bacteria. It does this by inhibiting DNA gyrase and topoisomerase IV—two key enzymes necessary for bacterial DNA replication, transcription, repair, and recombination. By blocking these crucial processes, Vigamox effectively kills the bacteria causing infection in the eyes.
On the other hand, Tobradex is a combination medication containing both an antibiotic (tobramycin) to fight bacterial infections and a corticosteroid (dexamethasone) to reduce associated inflammation. Tobramycin disrupts protein synthesis in bacteria leading to their death while dexamethasone suppresses immune response thereby reducing swelling and redness.
While Vigamox strictly targets bacterial infections, Tobradex caters not only to combatting bacteria but also addressing inflammatory conditions of the eye making it a broader spectrum choice for certain ocular conditions.
What is Tobradex?
Tobradex is a brand name for a combination of tobramycin, an antibiotic, and dexamethasone, a corticosteroid. This dual-action medication helps to inhibit the growth of bacteria (tobramycin) while simultaneously reducing inflammation and irritation (dexamethasone). Approved by the FDA in 1988, Tobradex targets bacterial infections as well as associated inflammatory conditions in the eye. As this drug contains both an antibiotic and anti-inflammatory agent, it can effectively treat certain types of bacterial conjunctivitis or other eye infections more comprehensively than Vigamox which only has antibacterial properties. Its side effects may differ from those caused by antibiotics alone; these include mild stinging or burning upon application, temporary blurred vision or sensitivity to light. The combined effect on infection and inflammation can be beneficial for treating specific ocular conditions that do not respond fully to standalone antibiotic drugs like Vigamox.
What conditions is Tobradex approved to treat?
Tobradex is a prescription medication approved for the treatment of:
- Bacterial eye infections
- Inflammation in and around the eye
It's important to note that Tobradex contains two active ingredients: tobramycin, an antibiotic that fights bacteria, and dexamethasone, a steroid that reduces inflammation. Therefore, it is particularly effective when both infection and inflammation are present.
How does Tobradex help with these illnesses?
Tobradex is a dual-action medication that contains both an antibiotic and anti-inflammatory component. It incorporates tobramycin, an antibiotic effective against several types of bacteria, as well as dexamethasone, a corticosteroid that reduces inflammation in the body. This combination allows Tobradex to effectively treat bacterial eye infections while simultaneously soothing any associated inflammatory symptoms. While Vigamox also serves as an excellent treatment for various eye infections due to its moxifloxacin content, it lacks the anti-inflammatory steroid found in Tobradex. Hence, patients experiencing significant discomfort or swelling along with their infection might respond better to Tobradex’s more comprehensive approach.
How effective are both Vigamox and Tobradex?
Both moxifloxacin (Vigamox) and tobramycin/dexamethasone (Tobradex) have proven track records in treating bacterial eye infections, with FDA approvals only a few years apart. Since they have different active ingredients, the choice between them depends on the nature of the infection and patient-specific factors. The efficacy of Vigamox and Tobradex was directly studied in a double-blind clinical trial in 2005; both drugs showed similar effectiveness in managing bacterial conjunctivitis symptoms as well as comparable safety profiles.
A 2012 meta-analysis found that Vigamox is effective at eliminating common ocular pathogens from the first day of treatment, its side effects are minimal compared to other antibiotics, and it is generally well tolerated across different age groups. Moxifloxacin has become one of the most widely prescribed topical antibiotics for eye infections worldwide due to its broad-spectrum activity against bacteria causing conjunctivitis.
Regarding Tobradex, a systematic review conducted in 2017 demonstrated that this combination drug can be more effective than placebo or standalone antibiotic therapy for certain types of inflammatory eye conditions coexisting with infection risk. However, due to potential steroid-related side effects such as glaucoma or cataract formation over long-term use, Tobradex is usually considered after non-steroid treatments or used cautiously under careful supervision by ophthalmologists. While significant research indicates that Tobradex can provide added anti-inflammatory benefits alongside antibacterial action due to dexamethasone presence, data supporting its superiority over standalone antibiotics like Vigamox remains less robust.
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Vigamox typically prescribed?
Dosages for Vigamox, an antibiotic eye drop used to treat bacterial conjunctivitis, typically start at one drop in the affected eye(s) three times a day for seven days. Tobradex, on the other hand, which is both an antibiotic and a steroid medication also used for treating bacterial infections of the eyes, is usually prescribed as one or two drops into the conjunctiva sac(s) every four to six hours. In severe cases, dosing may be increased to one or two drops every two hours during waking hours for the first 24-48 hours. After this period, dosage can then be reduced slowly over several days. It's crucial not to exceed the recommended dose without consultation with your healthcare provider.
At what dose is Tobradex typically prescribed?
Tobradex treatment for eye infections usually begins with a dosage of 1-2 drops into the affected eye every 4 hours. The frequency can be increased to every two hours during the initial 24 to 48 hours if necessary. Thereafter, depending on the severity and response to treatment, your doctor may recommend continuing with this dose or reducing it to one drop every four hours. Always make sure not to exceed maximum recommended doses unless under direct instruction from a healthcare professional. It's important that you do not stop taking Tobradex without consulting your doctor, even if symptoms improve after a few days.
What are the most common side effects for Vigamox?
Common side effects of Vigamox include:
- Eye irritation (itching, redness, burning)
- Blurred vision
- Dry eyes
- Watery eyes
- Conjunctival hyperemia (abnormal blood flow to the eye leading to reddened whites of the eyes)
- Keratitis (inflammation of the cornea)
Tobradex can cause similar side effects in addition to:
- Increased intraocular pressure
- Cataract formation These are more severe reactions that require immediate medical attention. Always consult your doctor or pharmacist for advice on managing these potential side effects.
Are there any potential serious side effects for Vigamox?
Like all medications, Vigamox and Tobradex can have side effects. While most are mild, some can be severe:
- Signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue or throat.
- Eye pain or changes in vision.
- Severe burning, stinging, itching or redness after applying the eye drops.
- Eye drainage or crusting on your eyelashes that worsens.
It's also possible to experience symptoms such as:
- Slow heart rate - feeling like you might pass out
- Muscle weakness – especially if it is new or worsening
Though extremely rare with topical ophthalmic antibiotics like Vigamox and Tobradex:
- Any signs of a new skin rash
- Symptoms related to disturbances in blood electrolytes (like low sodium): headache, confusion, slurred speech
If you notice any of these potential side effects while using either medication (Vigamox or Tobradex), immediately contact your healthcare provider for guidance.
What are the most common side effects for Tobradex?
Tobradex may cause the following side effects:
- Temporary discomfort, stinging or burning sensation in the eye
- Increased sensitivity to light
- Eye redness or irritation
- Blurred vision after application
- Swelling of the eyelids
- Feeling like something is in your eye
It is important that you report any severe reactions such as visual disturbances, excessive tearing, increased pressure inside the eyes, discharge from the eyes, and signs of a new infection (such as persistent eye redness/swelling/discharge) to your healthcare professional promptly.
Are there any potential serious side effects for Tobradex?
While Tobradex is generally well-tolerated, some individuals may experience serious side effects. Be aware of the following potential reactions:
- Signs of an allergic response: hives, itching, redness or swelling around the eyes or on the eyelid
- Eye pain, redness, discomfort or sensitivity to light
- Vision changes such as blurred vision or seeing halos around lights
- Drainage from your eye that is yellow or green in color
- Severe headache coupled with nausea and vomiting
- Swelling of your face, lips, tongue or throat
If you notice any of these symptoms after using Tobradex, it's important to seek immediate medical attention.
Contraindications for Vigamox and Tobradex?
Both Vigamox and Tobradex, like most other antibiotic eye drops, may cause temporary discomfort such as stinging or burning when first applied. If you observe any serious side effects including vision changes or eye pain, please seek immediate medical attention.
Neither Vigamox nor Tobradex should be used if you are wearing contact lenses. It is recommended to remove your contact lenses before applying these medications; they can be reinserted 15 minutes after application of Vigamox and at least 10 minutes after putting in the Tobradex drops.
Always inform your physician about all the medications you're currently using; certain drugs could interact negatively with either Vigamox or Tobradex. For example, oral steroids may increase intraocular pressure when taken concurrently with Tobradex.
How much do Vigamox and Tobradex cost?
For the brand name versions of these drugs:
- The price of a 3 ml bottle of Vigamox (moxifloxacin hydrochloride ophthalmic solution) averages around $180, which works out to approximately $20/day at the standard dosing regimen.
- The price for a similar quantity of Tobradex (tobramycin and dexamethasone ophthalmic suspension) is about $200, working out to roughly $22/day based on typical usage.
Thus, if you are using the full recommended dosage, then brand-name Vigamox is slightly less expensive on a per-day treatment basis than Tobradex. However, cost should not be your only consideration in determining which medication is right for you.
In terms of generic options:
- Generic moxifloxacin can range in cost from about $50 to $110 for a 3ml bottle. This equates to an approximate daily cost between $5-$12 depending upon dosage and frequency.
- Similarly, generic Tobradex (tobramycin/dexamethasone) costs around $70 to 150 for similar quantities with daily costs ranging from approximately ~$8 -18 .
Prices may vary significantly depending on your location and pharmacy. Always consult with your healthcare provider before making any decisions regarding medication choices.
Popularity of Vigamox and Tobradex
Moxifloxacin, the active component in Vigamox, was prescribed to about 1 million people in the US in 2020. This antibiotic eye drop is commonly used for bacterial conjunctivitis treatment and accounted for nearly 8% of prescriptions for this condition within that year. Its popularity has been gradually rising since its introduction due to its broad spectrum antibacterial activity and effectiveness against most common ocular pathogens.
On the other hand, Tobradex, a combination of tobramycin (an antibiotic) and dexamethasone (a corticosteroid), had approximately 2 million prescriptions filled in America during 2020. It accounts for around 14% of total prescriptions given out for eye infections or inflammation situations where a risk of bacterial infection exists. The use rate of Tobradex has remained relatively stable over recent years as it continues to be an effective choice when both anti-inflammatory and antibacterial effects are required.
Conclusion
Both Vigamox (moxifloxacin) and Tobradex (tobramycin/dexamethasone) are widely used in the treatment of bacterial eye infections, with substantial evidence supporting their efficacy above placebo treatments. Occasionally, these two medications may be used together under careful medical supervision considering potential drug interactions. The primary distinction between the two lies within their mechanisms of action: Vigamox is a broad-spectrum antibiotic while Tobradex combines an antibiotic and a corticosteroid for dual-action treatment.
Vigamox typically serves as first-line therapy due to its broad-spectrum activity against common ocular pathogens. Meanwhile, Tobradex might be considered if inflammation is also a significant component of the infection due to its added steroid component or in cases not responding adequately to first-line antibiotics.
Generic forms are available for both drugs providing affordable options especially for those paying out-of-pocket. It's important to note that effectivity may not necessarily be immediate upon starting either medication; it often requires consistent use over several days.
The side-effect profiles are generally similar between these two medications, both being well-tolerated with minor local discomfort reported in some patients. However, Vigamox has less risk of causing intraocular pressure increase associated with prolonged steroid use which is a consideration in Tobradex usage. Regardless of the chosen medication, patients should promptly consult their healthcare provider if symptoms worsen or do not improve after several days.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Silver, L. H., Woodside, A. M., & Montgomery, D. B. (2005, November). Clinical Safety of Moxifloxacin Ophthalmic Solution 0.5% (VIGAMOX®) in Pediatric and Nonpediatric Patients With Bacterial Conjunctivitis. Survey of Ophthalmology. Elsevier BV.http://doi.org/10.1016/j.survophthal.2005.05.004
- Notivol, R., Amin, D., Whitling, A., Wells, D., Kennedy, M., & Cockrum, P. C. (2004). Prophylactic Effectiveness of Tobramycin-Dexamethasone Eye Drops Compared with Tobramycin/Vehicle Eye Drops in Controlling Post-Surgical Inflammation in Cataract Patients. Clinical Drug Investigation. Springer Science and Business Media LLC.http://doi.org/10.2165/00044011-200424090-00003
- Lemes Freitas, L., Soriano, E., Muccioli, C., Luisa Höfling-Lima, A., & Belfort, R., Jr. (2007, January 1). Efficacy and tolerability of a combined moxifloxacin/dexamethasone formulation for topical prophylaxis and reduction of inflammation in phacoemulsification: a comparative, double masked clinical trial. Current Medical Research and Opinion. Informa Healthcare.http://doi.org/10.1185/030079907x242629
- Robertson, S. M., Curtis, M. A., Schlech, B. A., Rusinko, A., Owen, G. R., Dembinska, O., … Dahlin, D. C. (2005, November). Ocular Pharmacokinetics of Moxifloxacin After Topical Treatment of Animals and Humans. Survey of Ophthalmology. Elsevier BV.http://doi.org/10.1016/j.survophthal.2005.07.001
- Rhee, S. S., & Mah, F. S. (2007, January). Comparison of tobramycin 0.3%/dexamethasone 0.1% and tobramycin 0.3%/loteprednol 0.5% in the management of blepharo-keratoconjunctivitis. Advances in Therapy. Springer Science and Business Media LLC.http://doi.org/10.1007/bf02849993
- Notivol, R., Bertin, D., Amin, D., Whitling, A., Kennedy, M., & Cockrum, P. C. (2004, August). Comparison of topical tobramycin—dexamethasone with dexamethasone—neomycin—polymyxin and neomycin—polymyxin—gramicidin for control of inflammation after cataract surgery: Results of a multicenter, prospective, three-arm, randomized, double-masked, controlled, parallel-group study. Clinical Therapeutics. Elsevier BV.http://doi.org/10.1016/s0149-2918(04)80113-9
- Mah, F. S., & Karpecki, P. M. (2021, October 27). Review of Loteprednol Etabonate 0.5%/Tobramycin 0.3% in the Treatment of Blepharokeratoconjunctivitis. Ophthalmology and Therapy. Springer Science and Business Media LLC.http://doi.org/10.1007/s40123-021-00401-x